The global Auricular Vagus Nerve Stimulation Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Auricular Vagus Nerve Stimulation (aVNS) devices are medical tools designed to non-invasively stimulate the vagus nerve through the ear. These devices utilize electrical impulses delivered to the auricular branch of the vagus nerve, which is accessible at specific points on the ear. The stimulation aims to modulate neural activity to achieve therapeutic effects for a variety of conditions, such as epilepsy, depression, anxiety, and pain. aVNS devices offer a less invasive alternative to traditional vagus nerve stimulation, which typically requires surgical implantation of a stimulator. By targeting the nerve through the ear, these devices can potentially provide similar benefits with reduced risk and increased ease of use.

The auricular vagus nerve stimulation (aVNS) devices market is experiencing significant growth, driven by rising awareness and acceptance of neuromodulation therapies for various health conditions, including depression, epilepsy, and chronic pain. Major sales regions include North America and Europe, owing to advanced healthcare infrastructure, high prevalence of target disorders, and substantial R&D investments. The Asia-Pacific region is emerging as a lucrative market due to increasing healthcare expenditure and growing patient awareness. Market opportunities are abundant with ongoing technological advancements and the expanding application scope of aVNS devices. However, challenges such as stringent regulatory frameworks, high costs, and limited reimbursement policies pose barriers to market growth. Additionally, the need for extensive clinical validation to gain broader acceptance in the medical community remains a critical challenge.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Auricular Vagus Nerve Stimulation Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Auricular Vagus Nerve Stimulation Devices Market Report

Report Metric	Details
Report Name	Auricular Vagus Nerve Stimulation Devices Market
Segment by Type	Wearable aVNS Devices Handheld aVNS Devices
Segment by Application	Neurological Disorders Psychiatric Conditions Cardiovascular Diseases Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vagustim, Hoolest, Parasym, Pulsetto, Soterix Medical, Spark Biomedical, Truvaga, Neuvana, Sensate, Vivistim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Auricular Vagus Nerve Stimulation Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Auricular Vagus Nerve Stimulation Devices Market report?

Ans: The main players in the Auricular Vagus Nerve Stimulation Devices Market are Vagustim, Hoolest, Parasym, Pulsetto, Soterix Medical, Spark Biomedical, Truvaga, Neuvana, Sensate, Vivistim

What are the Application segmentation covered in the Auricular Vagus Nerve Stimulation Devices Market report?

Ans: The Applications covered in the Auricular Vagus Nerve Stimulation Devices Market report are Neurological Disorders, Psychiatric Conditions, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Auricular Vagus Nerve Stimulation Devices Market report?

Ans: The Types covered in the Auricular Vagus Nerve Stimulation Devices Market report are Wearable aVNS Devices, Handheld aVNS Devices

1 Study Coverage

1.1 Introduction to Auricular Vagus Nerve Stimulation Devices: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Auricular Vagus Nerve Stimulation Devices Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Wearable aVNS Devices

1.2.3 Handheld aVNS Devices

1.3 Market Segmentation by Application

1.3.1 Global Auricular Vagus Nerve Stimulation Devices Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Neurological Disorders

1.3.3 Psychiatric Conditions

1.3.4 Cardiovascular Diseases

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Auricular Vagus Nerve Stimulation Devices Revenue Estimates and Forecasts 2020-2031

2.2 Global Auricular Vagus Nerve Stimulation Devices Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Auricular Vagus Nerve Stimulation Devices Sales Estimates and Forecasts 2020-2031

2.4 Global Auricular Vagus Nerve Stimulation Devices Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Auricular Vagus Nerve Stimulation Devices Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Auricular Vagus Nerve Stimulation Devices Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Wearable aVNS Devices Market Size by Manufacturers

3.5.2 Handheld aVNS Devices Market Size by Manufacturers

3.6 Global Auricular Vagus Nerve Stimulation Devices Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Auricular Vagus Nerve Stimulation Devices Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Auricular Vagus Nerve Stimulation Devices Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Auricular Vagus Nerve Stimulation Devices Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Auricular Vagus Nerve Stimulation Devices Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Type (2020-2031)

6.4 North America Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Auricular Vagus Nerve Stimulation Devices Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Type (2020-2031)

7.4 Europe Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Auricular Vagus Nerve Stimulation Devices Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Auricular Vagus Nerve Stimulation Devices Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Type (2020-2031)

9.4 Central and South America Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Auricular Vagus Nerve Stimulation Devices Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Auricular Vagus Nerve Stimulation Devices Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Auricular Vagus Nerve Stimulation Devices Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Vagustim

11.1.1 Vagustim Corporation Information

11.1.2 Vagustim Business Overview

11.1.3 Vagustim Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.1.4 Vagustim Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Vagustim Auricular Vagus Nerve Stimulation Devices Sales by Product in 2024

11.1.6 Vagustim Auricular Vagus Nerve Stimulation Devices Sales by Application in 2024

11.1.7 Vagustim Auricular Vagus Nerve Stimulation Devices Sales by Geographic Area in 2024

11.1.8 Vagustim Auricular Vagus Nerve Stimulation Devices SWOT Analysis

11.1.9 Vagustim Recent Developments

11.2 Hoolest

11.2.1 Hoolest Corporation Information

11.2.2 Hoolest Business Overview

11.2.3 Hoolest Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.2.4 Hoolest Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Hoolest Auricular Vagus Nerve Stimulation Devices Sales by Product in 2024

11.2.6 Hoolest Auricular Vagus Nerve Stimulation Devices Sales by Application in 2024

11.2.7 Hoolest Auricular Vagus Nerve Stimulation Devices Sales by Geographic Area in 2024

11.2.8 Hoolest Auricular Vagus Nerve Stimulation Devices SWOT Analysis

11.2.9 Hoolest Recent Developments

11.3 Parasym

11.3.1 Parasym Corporation Information

11.3.2 Parasym Business Overview

11.3.3 Parasym Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.3.4 Parasym Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Parasym Auricular Vagus Nerve Stimulation Devices Sales by Product in 2024

11.3.6 Parasym Auricular Vagus Nerve Stimulation Devices Sales by Application in 2024

11.3.7 Parasym Auricular Vagus Nerve Stimulation Devices Sales by Geographic Area in 2024

11.3.8 Parasym Auricular Vagus Nerve Stimulation Devices SWOT Analysis

11.3.9 Parasym Recent Developments

11.4 Pulsetto

11.4.1 Pulsetto Corporation Information

11.4.2 Pulsetto Business Overview

11.4.3 Pulsetto Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.4.4 Pulsetto Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Pulsetto Auricular Vagus Nerve Stimulation Devices Sales by Product in 2024

11.4.6 Pulsetto Auricular Vagus Nerve Stimulation Devices Sales by Application in 2024

11.4.7 Pulsetto Auricular Vagus Nerve Stimulation Devices Sales by Geographic Area in 2024

11.4.8 Pulsetto Auricular Vagus Nerve Stimulation Devices SWOT Analysis

11.4.9 Pulsetto Recent Developments

11.5 Soterix Medical

11.5.1 Soterix Medical Corporation Information

11.5.2 Soterix Medical Business Overview

11.5.3 Soterix Medical Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.5.4 Soterix Medical Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Soterix Medical Auricular Vagus Nerve Stimulation Devices Sales by Product in 2024

11.5.6 Soterix Medical Auricular Vagus Nerve Stimulation Devices Sales by Application in 2024

11.5.7 Soterix Medical Auricular Vagus Nerve Stimulation Devices Sales by Geographic Area in 2024

11.5.8 Soterix Medical Auricular Vagus Nerve Stimulation Devices SWOT Analysis

11.5.9 Soterix Medical Recent Developments

11.6 Spark Biomedical

11.6.1 Spark Biomedical Corporation Information

11.6.2 Spark Biomedical Business Overview

11.6.3 Spark Biomedical Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.6.4 Spark Biomedical Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Spark Biomedical Recent Developments

11.7 Truvaga

11.7.1 Truvaga Corporation Information

11.7.2 Truvaga Business Overview

11.7.3 Truvaga Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.7.4 Truvaga Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Truvaga Recent Developments

11.8 Neuvana

11.8.1 Neuvana Corporation Information

11.8.2 Neuvana Business Overview

11.8.3 Neuvana Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.8.4 Neuvana Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Neuvana Recent Developments

11.9 Sensate

11.9.1 Sensate Corporation Information

11.9.2 Sensate Business Overview

11.9.3 Sensate Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.9.4 Sensate Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Sensate Recent Developments

11.10 Vivistim

11.10.1 Vivistim Corporation Information

11.10.2 Vivistim Business Overview

11.10.3 Vivistim Auricular Vagus Nerve Stimulation Devices Product Models, Descriptions and Specifications

11.10.4 Vivistim Auricular Vagus Nerve Stimulation Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Vivistim Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Auricular Vagus Nerve Stimulation Devices Industry Chain

12.2 Auricular Vagus Nerve Stimulation Devices Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Auricular Vagus Nerve Stimulation Devices Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Auricular Vagus Nerve Stimulation Devices Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Auricular Vagus Nerve Stimulation Devices Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Auricular Vagus Nerve Stimulation Devices Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Auricular Vagus Nerve Stimulation Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Auricular Vagus Nerve Stimulation Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Auricular Vagus Nerve Stimulation Devices Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Auricular Vagus Nerve Stimulation Devices Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Auricular Vagus Nerve Stimulation Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Auricular Vagus Nerve Stimulation Devices Sales by Region (2020-2025) & (K Units)

Table 8. Global Auricular Vagus Nerve Stimulation Devices Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Auricular Vagus Nerve Stimulation Devices Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Auricular Vagus Nerve Stimulation Devices Sales Share by Manufacturers (2020-2025)

Table 12. Global Auricular Vagus Nerve Stimulation Devices Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Auricular Vagus Nerve Stimulation Devices Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Auricular Vagus Nerve Stimulation Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Auricular Vagus Nerve Stimulation Devices as of 2024)

Table 16. Global Auricular Vagus Nerve Stimulation Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Auricular Vagus Nerve Stimulation Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Auricular Vagus Nerve Stimulation Devices Manufacturing Base and Headquarters

Table 19. Global Auricular Vagus Nerve Stimulation Devices Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Auricular Vagus Nerve Stimulation Devices Sales by Type (2020-2025) & (K Units)

Table 23. Global Auricular Vagus Nerve Stimulation Devices Sales by Type (2026-2031) & (K Units)

Table 24. Global Auricular Vagus Nerve Stimulation Devices Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Auricular Vagus Nerve Stimulation Devices Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Auricular Vagus Nerve Stimulation Devices ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Auricular Vagus Nerve Stimulation Devices Sales by Application (2020-2025) & (K Units)

Table 29. Global Auricular Vagus Nerve Stimulation Devices Sales by Application (2026-2031) & (K Units)

Table 30. Auricular Vagus Nerve Stimulation Devices High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Auricular Vagus Nerve Stimulation Devices Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Auricular Vagus Nerve Stimulation Devices Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Auricular Vagus Nerve Stimulation Devices ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Auricular Vagus Nerve Stimulation Devices Growth Accelerators and Market Barriers

Table 37. North America Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Auricular Vagus Nerve Stimulation Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Auricular Vagus Nerve Stimulation Devices Growth Accelerators and Market Barriers

Table 40. Europe Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Auricular Vagus Nerve Stimulation Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Growth Accelerators and Market Barriers

Table 45. Southeast Asia Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Auricular Vagus Nerve Stimulation Devices Investment Opportunities and Key Challenges

Table 47. Central and South America Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Vagustim Corporation Information

Table 51. Vagustim Description and Major Businesses

Table 52. Vagustim Product Models, Descriptions and Specifications

Table 53. Vagustim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Vagustim Sales Value Proportion by Product in 2024

Table 55. Vagustim Sales Value Proportion by Application in 2024

Table 56. Vagustim Sales Value Proportion by Geographic Area in 2024

Table 57. Vagustim Auricular Vagus Nerve Stimulation Devices SWOT Analysis

Table 58. Vagustim Recent Developments

Table 59. Hoolest Corporation Information

Table 60. Hoolest Description and Major Businesses

Table 61. Hoolest Product Models, Descriptions and Specifications

Table 62. Hoolest Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Hoolest Sales Value Proportion by Product in 2024

Table 64. Hoolest Sales Value Proportion by Application in 2024

Table 65. Hoolest Sales Value Proportion by Geographic Area in 2024

Table 66. Hoolest Auricular Vagus Nerve Stimulation Devices SWOT Analysis

Table 67. Hoolest Recent Developments

Table 68. Parasym Corporation Information

Table 69. Parasym Description and Major Businesses

Table 70. Parasym Product Models, Descriptions and Specifications

Table 71. Parasym Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Parasym Sales Value Proportion by Product in 2024

Table 73. Parasym Sales Value Proportion by Application in 2024

Table 74. Parasym Sales Value Proportion by Geographic Area in 2024

Table 75. Parasym Auricular Vagus Nerve Stimulation Devices SWOT Analysis

Table 76. Parasym Recent Developments

Table 77. Pulsetto Corporation Information

Table 78. Pulsetto Description and Major Businesses

Table 79. Pulsetto Product Models, Descriptions and Specifications

Table 80. Pulsetto Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Pulsetto Sales Value Proportion by Product in 2024

Table 82. Pulsetto Sales Value Proportion by Application in 2024

Table 83. Pulsetto Sales Value Proportion by Geographic Area in 2024

Table 84. Pulsetto Auricular Vagus Nerve Stimulation Devices SWOT Analysis

Table 85. Pulsetto Recent Developments

Table 86. Soterix Medical Corporation Information

Table 87. Soterix Medical Description and Major Businesses

Table 88. Soterix Medical Product Models, Descriptions and Specifications

Table 89. Soterix Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Soterix Medical Sales Value Proportion by Product in 2024

Table 91. Soterix Medical Sales Value Proportion by Application in 2024

Table 92. Soterix Medical Sales Value Proportion by Geographic Area in 2024

Table 93. Soterix Medical Auricular Vagus Nerve Stimulation Devices SWOT Analysis

Table 94. Soterix Medical Recent Developments

Table 95. Spark Biomedical Corporation Information

Table 96. Spark Biomedical Description and Major Businesses

Table 97. Spark Biomedical Product Models, Descriptions and Specifications

Table 98. Spark Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Spark Biomedical Recent Developments

Table 100. Truvaga Corporation Information

Table 101. Truvaga Description and Major Businesses

Table 102. Truvaga Product Models, Descriptions and Specifications

Table 103. Truvaga Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Truvaga Recent Developments

Table 105. Neuvana Corporation Information

Table 106. Neuvana Description and Major Businesses

Table 107. Neuvana Product Models, Descriptions and Specifications

Table 108. Neuvana Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Neuvana Recent Developments

Table 110. Sensate Corporation Information

Table 111. Sensate Description and Major Businesses

Table 112. Sensate Product Models, Descriptions and Specifications

Table 113. Sensate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Sensate Recent Developments

Table 115. Vivistim Corporation Information

Table 116. Vivistim Description and Major Businesses

Table 117. Vivistim Product Models, Descriptions and Specifications

Table 118. Vivistim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Vivistim Recent Developments

Table 120. Key Raw Materials Distribution

Table 121. Raw Materials Key Suppliers

Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 123. Milestones in Production Technology Evolution

Table 124. Distributors List

Table 125. Market Trends and Market Evolution

Table 126. Market Drivers and Opportunities

Table 127. Market Challenges, Risks, and Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Auricular Vagus Nerve Stimulation Devices Product Picture

Figure 2. Global Auricular Vagus Nerve Stimulation Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Wearable aVNS Devices Product Picture

Figure 4. Handheld aVNS Devices Product Picture

Figure 5. Global Auricular Vagus Nerve Stimulation Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Neurological Disorders

Figure 7. Psychiatric Conditions

Figure 8. Cardiovascular Diseases

Figure 9. Others

Figure 10. Auricular Vagus Nerve Stimulation Devices Report Years Considered

Figure 11. Global Auricular Vagus Nerve Stimulation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 13. Global Auricular Vagus Nerve Stimulation Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Auricular Vagus Nerve Stimulation Devices Revenue Market Share by Region (2020-2031)

Figure 15. Global Auricular Vagus Nerve Stimulation Devices Sales (2020-2031) & (K Units)

Figure 16. Global Auricular Vagus Nerve Stimulation Devices Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global Auricular Vagus Nerve Stimulation Devices Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Volume Market Share in 2024

Figure 19. Global Auricular Vagus Nerve Stimulation Devices Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Wearable aVNS Devices Revenue Market Share by Manufacturer in 2024

Figure 22. Handheld aVNS Devices Revenue Market Share by Manufacturer in 2024

Figure 23. Global Auricular Vagus Nerve Stimulation Devices Sales Market Share by Type (2020-2031)

Figure 24. Global Auricular Vagus Nerve Stimulation Devices Revenue Market Share by Type (2020-2031)

Figure 25. Global Auricular Vagus Nerve Stimulation Devices Sales Market Share by Application (2020-2031)

Figure 26. Global Auricular Vagus Nerve Stimulation Devices Revenue Market Share by Application (2020-2031)

Figure 27. North America Auricular Vagus Nerve Stimulation Devices Sales YoY (2020-2031) & (K Units)

Figure 28. North America Auricular Vagus Nerve Stimulation Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) in 2024

Figure 30. North America Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Type (2020- 2031)

Figure 31. North America Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 32. North America Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Application (2020-2031)

Figure 33. North America Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 34. US Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 35. Canada Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 36. Mexico Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 37. Europe Auricular Vagus Nerve Stimulation Devices Sales YoY (2020-2031) & (K Units)

Figure 38. Europe Auricular Vagus Nerve Stimulation Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Europe Top 5 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) in 2024

Figure 40. Europe Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Type (2020-2031)

Figure 41. Europe Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 42. Europe Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Application (2020-2031)

Figure 43. Europe Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. Germany Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 45. France Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 46. U.K. Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 47. Italy Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 48. Russia Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales YoY (2020-2031) & (K Units)

Figure 50. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Top 8 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) in 2024

Figure 52. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Type (2020- 2031)

Figure 53. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 54. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Application (2020-2031)

Figure 55. Asia-Pacific Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Indonesia Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 57. Japan Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 58. South Korea Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 59. China Taiwan Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 60. India Auricular Vagus Nerve Stimulation Devices Revenue (2020-2031) & (US$ Million)

Figure 61. Central and South America Auricular Vagus Nerve Stimulation Devices Sales YoY (2020-2031) & (K Units)

Figure 62. Central and South America Auricular Vagus Nerve Stimulation Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Central and South America Top 5 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) in 2024

Figure 64. Central and South America Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Type (2021-2031)

Figure 65. Central and South America Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 66. Central and South America Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Application (2020-2031)

Figure 67. Central and South America Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Brazil Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 69. Argentina Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 70. Middle East, and Africa Auricular Vagus Nerve Stimulation Devices Sales YoY (2020-2031) & (K Units)

Figure 71. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Middle East and Africa Top 5 Manufacturers Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) in 2024

Figure 73. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Type (2021-2031)

Figure 74. South America Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Sales Volume (K Units) by Application (2020-2031)

Figure 76. Middle East and Africa Auricular Vagus Nerve Stimulation Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. GCC Countries Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 78. Turkey Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 79. Egypt Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 80. South Africa Auricular Vagus Nerve Stimulation Devices Revenue (2020-2025) & (US$ Million)

Figure 81. Auricular Vagus Nerve Stimulation Devices Industry Chain Mapping

Figure 82. Regional Auricular Vagus Nerve Stimulation Devices Manufacturing Base Distribution (%)

Figure 83. Global Auricular Vagus Nerve Stimulation Devices Production Market Share by Region (2020-2031)

Figure 84. Auricular Vagus Nerve Stimulation Devices Production Process

Figure 85. Regional Auricular Vagus Nerve Stimulation Devices Production Cost Structure

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions